What is the best dose of aspirin in association with P2Y12 antagonists?

被引:3
|
作者
Cattaneo, Marco [1 ]
机构
[1] Univ Milan, Osped San Paolo, I-20142 Milan, Italy
关键词
P2Y(12); RECEPTOR;
D O I
10.1136/hrt.2010.216812
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:263 / 264
页数:2
相关论文
共 50 条
  • [21] Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists
    Richard C. Becker
    Journal of Thrombosis and Thrombolysis, 2009, 28 : 513 - 514
  • [22] Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists
    Becker, Richard C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (04) : 513 - 514
  • [23] Course of platelet miRNAs after cessation of P2Y12 antagonists
    Jaeger, Bernhard
    Stojkovic, Stefan
    Haller, Paul M.
    Piackova, Edith
    Kahl, Beatrice S.
    Andric, Tijana
    Vargas, Kris G.
    Wojta, Johann
    Huber, Kurt
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (08)
  • [24] The P2Y12 Antagonists, 2MeSAMP and Cangrelor, Inhibit Platelet Activation through P2Y12/Gi-Dependent Mechanism
    Xiang, Binggang
    Zhang, Guoying
    Ren, Hongmei
    Sunkara, Manjula
    Morris, Andrew J.
    Gartner, T. Kent
    Smyth, Susan S.
    Li, Zhenyu
    PLOS ONE, 2012, 7 (12):
  • [25] Pharmacokinetics and Pharmacodynamics of Approved and Investigational P2Y12 Receptor Antagonists
    Schilling, Uta
    Dingemanse, Jasper
    Ufer, Mike
    CLINICAL PHARMACOKINETICS, 2020, 59 (05) : 545 - 566
  • [26] Mode of action of P2Y12 antagonists as inhibitors of platelet function
    Iyu, David
    Glenn, Jackie R.
    White, Ann E.
    Fox, Sue C.
    van Giezen, Hans
    Nylander, Sven
    Heptinstall, Stan
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (01) : 96 - 106
  • [27] Mode of action of P2Y12 antagonists as inhibitors of platelet function
    Glenn, J.
    Iyu, D. E.
    White, A. E.
    Fox, S. C.
    van Giezen, H.
    Nylander, S.
    Heptinstall, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 319 - 320
  • [28] Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry
    Penz S.M.
    Bernlochner I.
    Tóth O.
    Lorenz R.
    Calatzis A.
    Siess W.
    Thrombosis Journal, 8 (1)
  • [29] Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin
    Varenhorst, Christoph
    James, Stefan
    Erlinge, David
    Braun, Oscar O.
    Brandt, John T.
    Winters, Kenneth J.
    Jakubowski, Joseph A.
    Olofsson, Sylvia
    Wallentin, Lars
    Slegbahn, Agneta
    AMERICAN HEART JOURNAL, 2009, 157 (03) : 562.e1 - 562.e9
  • [30] Platelet function assays that assess response to P2Y12 antagonists vary widely in their sensitivities to low levels of P2Y12 receptor blockade
    Judge, H. M.
    Buckland, R. J.
    Sugidachi, A.
    Jakubowski, J. A.
    Storey, R. F.
    EUROPEAN HEART JOURNAL, 2008, 29 : 835 - 835